Clinical significance of serum autoantibodies in idiopathic interstitial pneumonia

Journal of Korean Medical Science

Volumn 28, Issue 5, 2013, Pages 731-737

  Kang, Bo Hyoung ^a   Park, Jin Kyeong ^a   Roh, Jae Hyung ^a   Song, Jin Woo ^a   Lee, Chang Keun ^a   Kim, Miyoung ^a   Jang, Se Jin ^a   Colby, Thomas V ^b   Kim, Dong Soon ^a  

^a University of Ulsan   (South Korea)

^b MAYO CLINIC   (United States)

Author keywords

Antinuclear antibody; Autoantibody; Connective tissue disease; Cryptogenic organizing pneumonia; Idiopathic interstitial pneumonias; Idiopathic pulmonary fibrosis; Incidence; Nonspecific interstitial pneumonia; Predictive factor; Rheumatoid factor

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; RHEUMATOID FACTOR;

AGED; ARTICLE; BLOOD; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONNECTIVE TISSUE DISEASE; FEMALE; FIBROSING ALVEOLITIS; FOLLOW UP; HUMAN; INCIDENCE; INTERSTITIAL PNEUMONIA; MALE; MIDDLE AGED; PATHOLOGY; PREDICTIVE FACTOR; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; TERTIARY CARE CENTER;

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CONNECTIVE TISSUE DISEASE; CRYPTOGENIC ORGANIZING PNEUMONIA; IDIOPATHIC INTERSTITIAL PNEUMONIAS; IDIOPATHIC PULMONARY FIBROSIS; INCIDENCE; NONSPECIFIC INTERSTITIAL PNEUMONIA; PREDICTIVE FACTOR; RHEUMATOID FACTOR;

AGED; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; COHORT STUDIES; CONNECTIVE TISSUE DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IDIOPATHIC INTERSTITIAL PNEUMONIAS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RHEUMATOID FACTOR; RISK FACTORS; TERTIARY CARE CENTERS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84878608981     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2013.28.5.731     Document Type: Article

References (40)

1. American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias: this joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002; 165: 277-304.
2. Park JH, Kim DS, Park IN, Jang SJ, Kitaichi M, Nicholson AG, Colby TV. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med 2007; 175: 705-11.
3. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788- 824.
4. Homma Y, Ohtsuka Y, Tanimura K, Kusaka H, Munakata M, Kawakami Y, Ogasawara H. Can interstitial pneumonia as the sole presentation of collagen vascular diseases be differentiated from idiopathic interstitial pneumonia? Respiration 1995; 62: 248-51.
5. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
6. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
7. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975; 292: 344-7.
8. LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001; 28: 1573-6.
9. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554-8.
10. AlarcÓn-Segovia D, Cardiel MH. Comparison between 3 diagnostic criteria for mixed connective tissue disease: study of 593 patients. J Rheumatol 1989; 16: 328-34.
11. Mosca M, Tani C, Bombardieri S. Undifferentiated connective tissue diseases (UCTD): a new frontier for rheumatology. Best Pract Res Clin Rheumatol 2007; 21: 1011-23.
12. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG, et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-92.
13. Lightfoot RW Jr, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ, Arend WP, Calabrese LH, Leavitt RY, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990; 33: 1088-93.
14. Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990; 33: 1094-100.
15. Kim DS, Yoo B, Lee JS, Kim EK, Lim CM, Lee SD, Koh Y, Kim WS, Kim WD, Colby TV, et al. The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19: 121-7.
16. Jegal Y, Kim DS, Shim TS, Lim CM, Do Lee S, Koh Y, Kim WS, Kim WD, Lee JS, Travis WD, et al. Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia. Am J Respir Crit Care Med 2005; 171: 639-44.
17. Song JW, Do KH, Kim MY, Jang SJ, Colby TV, Kim DS. Pathologic and radiologic differences between idiopathic and collagen vascular diseaserelated usual interstitial pneumonia. Chest 2009; 136: 23-30.
18. Scadding JG, Hinson KF. Diffuse fibrosing alveolitis (diffuse interstitial fibrosis of the lungs): correlation of histology at biopsy with prognosis. Thorax 1967; 22: 291-304.
19. Turner-Warwick M, Haslam P, Weeks J. Antibodies in some chronic fibrosing lung diseases: II. immunofluorescent studies. Clin Allergy 1971; 1: 209-19.
20. Nagaya H, Sieker HO. Pathogenetic mechanisms of interstitial pulmonary fibrosis in patients with serum antinuclear factor: a histologic and clinical correlation. Am J Med 1972; 52: 51-62.
21. Chapman JR, Charles PJ, Venables PJ, Thompson PJ, Haslam PL, Maini RN, Turner Warwick ME. Definition and clinical relevance of antibodies to nuclear ribonucleoprotein and other nuclear antigens in patients with cryptogenic fibrosing alveolitis. Am Rev Respir Dis 1984; 130: 439-43.
22. Shmerling RH, Delbanco TL. The rheumatoid factor: an analysis of clinical utility. Am J Med 1991; 91: 528-34.
23. Fischer A, Pfalzgraf FJ, Feghali-Bostwick CA, Wright TM, Curran-Everett D, West SG, Brown KK. Anti-th/to-positivity in a cohort of patients with idiopathic pulmonary fibrosis. J Rheumatol 2006; 33: 1600-5.
24. Mittoo S, Gelber AC, Christopher-Stine L, Horton MR, Lechtzin N, Danoff SK. Ascertainment of collagen vascular disease in patients presenting with interstitial lung disease. Respir Med 2009; 103: 1152-8.
25. Tan EM, Feltkamp TE, Smolen JS, Butcher B, Dawkins R, Fritzler MJ, Gordon T, Hardin JA, Kalden JR, Lahita RG, et al. Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum 1997; 40: 1601-11.
26. Kavanaugh A, Tomar R, Reveille J, Solomon DH, Homburger HA. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens: American College of Pathologists: American College of Pathologists. Arch Pathol Lab Med 2000; 124: 71-81.
27. Solomon DH, Kavanaugh AJ, Schur PH; American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines. Evidence- based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum 2002; 47: 434-44.
28. Fischer A, West SG, Swigris JJ, Brown KK, du Bois RM. Connective tissue disease-associated interstitial lung disease: a call for clarification. Chest 2010; 138: 251-6.
29. Rantapää-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, Sundin U, van Venrooij WJ. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003; 48: 2741-9.
30. Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH, Habibuw MR, Vandenbroucke JP, Dijkmans BA. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004; 50: 380-6.
31. Van Venrooij WJ, van Beers JJ, Pruijn GJ. Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis. Ann N Y Acad Sci 2008; 1143: 268-85.
32. Von Mühlen CA, Tan EM. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 1995; 24: 323-58.
33. Reveille JD, Solomon DH; American College of Rheumatology Ad Hoc Committee of Immunologic Testing Guidelines. Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl-70, and nucleolar antibodies. Arthritis Rheum 2003; 49: 399-412.
34. Conrad K, Mehlhorn J. Diagnostic and prognostic relevance of autoantibodies in uranium miners. Int Arch Allergy Immunol 2000; 123: 77-91.
35. Hayashi N, Koshiba M, Nishimura K, Sugiyama D, Nakamura T, Morinobu S, Kawano S, Kumagai S. Prevalence of disease-specific antinuclear antibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period. Mod Rheumatol 2008; 18: 153-60.
36. Parker JC, Bunn CC. Sensitivity of the Phadia EliA connective tissue disease screen for less common disease-specific autoantibodies. J Clin Pathol 2011; 64: 631-3.
37. Castelino FV, Goldberg H, Dellaripa PF. The impact of rheumatological evaluation in the management of patients with interstitial lung disease. Rheumatology (Oxford) 2011; 50: 489-93.
38. Newkirk MM. Rheumatoid factors: what do they tell us? J Rheumatol 2002; 29: 2034-40.
39. Litwin SD, Singer JM. Studies of the incidence and significance of antigamma globulin factors in the aging. Arthritis Rheum 1965; 8: 538-50.
40. Cammarata RJ, Rodnan GP, Fennell RH. Serum anti-gamma-globulin and antinuclear factors in the aged. JAMA 1967; 199: 455-8.